药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hexobarbital
Prasugrel
The risk or severity of bleeding can be increased when Prasugrel is combined with Nintedanib.
Hexobarbital
Fibrinolysin
The risk or severity of bleeding can be increased when Fibrinolysin is combined with Nintedanib.
Hexobarbital
Beraprost
The risk or severity of bleeding can be increased when Beraprost is combined with Nintedanib.
Hexobarbital
Ancrod
The risk or severity of bleeding can be increased when Ancrod is combined with Nintedanib.
Hexobarbital
Defibrotide
The risk or severity of bleeding can be increased when Defibrotide is combined with Nintedanib.
Hexobarbital
Desmoteplase
The risk or severity of bleeding can be increased when Desmoteplase is combined with Nintedanib.
Hexobarbital
Ximelagatran
The risk or severity of bleeding can be increased when Ximelagatran is combined with Nintedanib.
Hexobarbital
Coumarin
The risk or severity of bleeding can be increased when Coumarin is combined with Nintedanib.
Hexobarbital
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Nintedanib.
Hexobarbital
Erdafitinib
The serum concentration of Nintedanib can be increased when it is combined with Erdafitinib.
Hexobarbital
Thyrotropin
The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Nintedanib.
Hexobarbital
Benzylthiouracil
The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Nintedanib.
Hexobarbital
Elcatonin
The therapeutic efficacy of Elcatonin can be decreased when used in combination with Nintedanib.
Hexobarbital
Methylthiouracil
The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Nintedanib.
Hexobarbital
3,5-diiodothyropropionic acid
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Nintedanib.
Hexobarbital
Protirelin
The therapeutic efficacy of Protirelin can be decreased when used in combination with Nintedanib.
Hexobarbital
Potassium perchlorate
The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Nintedanib.
Hexobarbital
Thyroid, porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Nintedanib.
Hexobarbital
Dibromotyrosine
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Nintedanib.
Hexobarbital
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Nintedanib.